LabCorp commits $2M to SynapDx's autism blood test; NeuroPace preps for FDA panel vote;

 @FierceMedDev: Report: Middle East, North Africa poised for major device and Dx growth. Item | Follow @FierceMedDev

 @MarkHFierce: Interesting challenge to the supremacy of surgical robots for a key procedure. News | Follow @MarkHFierce

 @DamianFierce: Allergan won FDA approval for its new breast implant, but the agency wants quite a bit of post-market data. Story | Follow @DamianFierce

> NeuroPace will go before the FDA's Neurological Devices Panel on Feb. 22 to present the company's PMA application for the RNS System, a neurostimulation device designed to treat epilepsy. Item

> LabCorp ($LH) is committing $2 million to SynapDx's ongoing development of an autism spectrum disorder diagnostics blood test. Release

> The FDA wants industry and public input on how to minimize effects on the production and supply of medical devices in the face of weather and natural disasters. Release

> Torax Medical's reflux-management device to treat gastroesophageal reflux disease has continued to generate positive data at the three-year mark, according to a study published in the New England Journal of Medicine. Release

> The FDA cited Medsys for allegedly not having procedures in place for handling complaints or addressing design changes for its lap loop surgical tool. Warning letter

> The next medical device implant may be completely custom-made. Scientists from Cornell University and Weill Cornell Medical College used a 3-D printer and collagen-supported cartilage cells to grow artificial children's ears. Story

> The global breast biopsy device market should reach the $490 million mark by 2017, Millennium Research Group concludes in a new industry report. Item

Biotech News

 @FierceBiotech: Ambit joins biotech IPO queue, seeks $58M as AML drug nears PhIII. News | Follow @FierceBiotech

@JohnCFierce: Manhandled by FDA in 2011, now a "no" in Europe. Gentium shares wrecked by fresh round of regulatory woes for lead drug. More | Follow @JohnCFierce

> Buzz: Shire's new CEO sends mixed signals on "transformational" M&A strategy. Story

> Investors bankroll unique brains-and-beauty collaboration with $30M round. Article

Pharma News

@FiercePharma: Warning to Roche execs: Don't drink too much at a conference. Your peers are watching (and may report you). More | Follow @FiercePharma

@EricPFierce: Yet another pharmaceutical supplier makes a move on India to get in on the growing market there. News | Follow @EricPFierce

@AlisonBFierce: Rising vaccine prices mean fewer children are immunized. But competition from small vaccinemakers could lower costs. Story | Follow @AlisonBFierce

> China leaps ahead of U.S. with plans for track-and-trace system. Item

> German cost agency spurns Xalkori, Komboglyze. Story

Pharma Manufacturing News

> Drug shortages play role in growth at West Pharmaceutical. Story

> Mylan closes on oncology API plant as it rolls through India. Report

> China mandates track and trace while U.S. dithers. Article

> Dutch excipient player makes move on India. More

Vaccines News

> Rising vaccine prices mean fewer children immunized. News

> Indian court: Sanofi doesn't owe taxes on Shantha merger. Report

> Universal flu vaccine still 5 to 10 years away. Item

> HealthMap helps patients locate nearby vaccination sites. Article

> Australia begins vaccinating boys for HPV. Story